|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-4-3
|
|
pubmed:abstractText |
Pentavalent antimonial compounds, the mainstay in the treatment of the various forms of leishmaniasis, have considerable toxicity, are difficult to administer and expensive. We describe a safe and efficient therapeutic modality using a spring-loaded and air-powered device for the intralesional injection of a high-velocity meglumine antimoniate microspray in a patient with cutaneous leishmaniasis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1018-8665
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2003 S. Karger AG, Basel
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
206
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
269-72
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12673089-Adolescent,
pubmed-meshheading:12673089-Antimony,
pubmed-meshheading:12673089-Antiprotozoal Agents,
pubmed-meshheading:12673089-Equipment Design,
pubmed-meshheading:12673089-Humans,
pubmed-meshheading:12673089-Injections, Intralesional,
pubmed-meshheading:12673089-Leishmaniasis, Cutaneous,
pubmed-meshheading:12673089-Male,
pubmed-meshheading:12673089-Meglumine,
pubmed-meshheading:12673089-Organometallic Compounds
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
|
|
pubmed:affiliation |
Department of Dermatology, University of Regensburg, Germany. bogenrieder@wistar.upenn.edu
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
